ecrin-mdr-crcClinical2016colorectal cancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2637344Japan4ECRIN MDRCompletedfalseA phase I study of combination immunotherapy with five peptides cocktail, CpG, and immune modulators for patients with advanced or metastatic colorectal cancerInterventions: combination immunotherapy Primary outcome(s): safety Study Design: Single arm Non-randomized2016-04-152637344JPRN-UMIN000022082